An Injectable PEG-BSA-Coumarin-GOx Hydrogel for Fluorescence Turn-on Glucose Detection
Authors:
- 19 August 2015
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 177 (5) , 1115-1126
Abstract
Diabetes mellitus is a chronic metabolic disorder, requiring vigilant monitoring of blood glucose levels. In this study, an injectable fluorescent enzymatic hydrogel was designed for rapid glucose detection. The leakage-free glucose-responsive hydrogel was constructed by the covalent linkage of a multi-arm poly-(ethylene glycol) (PEG), bovine serum albumin (BSA), glucose oxidase (GOx), and 4-(aminomethyl)-6,7-dimethoxycoumarin (Coumarin-NH2). The GOx serves as glucose-recognition element and the pH-sensitive Coumarin-NH2 as a fluorescence turn-on reporter. The material properties of the fluorescent hydrogel were systematically characterized which show high elasticity with good mechanical strength. Upon the addition of glucose, the as-developed fluorescent hydrogel shows a fast response time, good sensitivity, and good reproducibility at physiological pH and ambient temperature. The glucose-sensing mechanism is based on the oxidation of the glucose by GOx that generates protons to change the local pH. Consequently, protonation of the covalently immobilized and pH-sensitive Coumarin-NH2 turns on the fluorescence of the coumarin. The fluorescence hydrogel developed holds great promise as an injectable, implantable glucose-sensing biomaterials for in vivo continuous glucose monitoring.Keywords
This publication has 27 references indexed in Scilit:
- Functionalized aligned silver nanorod arrays for glucose sensing through surface enhanced Raman scatteringRSC Advances, 2014
- Technologies for Continuous Glucose Monitoring: Current Problems and Future PromisesJournal of Diabetes Science and Technology, 2010
- Fluorescence Sensing of Glucose Using Glucose Oxidase Modified by PVA-Pyrene Prepared via “Click” ChemistryBiomacromolecules, 2009
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- Fluorescence-based glucose sensorsBiosensors and Bioelectronics, 2005
- Home blood glucose biosensors: a commercial perspectiveBiosensors and Bioelectronics, 2005
- Continuous Glucose MonitoringDiabetes Care, 2005
- Fluorescence Resonance Energy Transfer Between Quantum Dot Donors and Dye-Labeled Protein AcceptorsJournal of the American Chemical Society, 2003
- Luminescent quantum dots for multiplexed biological detection and imagingCurrent Opinion in Biotechnology, 2002
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993